Restasis - Cyclosporine ophthalmic emulsion, 0.05% Allergan - Drug increases tear production in patients with chronic dry eye due to ocular inflammation

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2003年 / 38卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 36 条
  • [1] Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
    Deveney, Tatiana
    Asbell, Penny A.
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 569 - 576
  • [2] PERSIST: Physician's Evaluation of Restasis (R) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
    Mah, Francis
    Milner, Mark
    Yiu, Samuel
    Donnenfeld, Eric
    Conway, Taryn M.
    Hollander, David A.
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1971 - 1976
  • [3] The IMPAPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye
    Stonecipher, Karl G.
    Torkildsen, Gail L.
    Ousler, George W., III
    Morris, Scot
    Villanueva, Linda
    Hollander, David A.
    CLINICAL OPHTHALMOLOGY, 2016, 10 : 887 - 895
  • [4] An investigation of 0.05% cyclosporine ophthalmic emulsion in reducing ocular surface staining and impact on visual performance in individuals with dry eye
    Torkildsen, Gail
    Stonecipher, Karl
    Ousler, George W.
    Villanueva, Linda
    Hollander, David A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Cyclosporine 0.05% ophthalmic emulsion for the treatment of radiation-associated dry eye in children
    Hoehn, Mary Ellen
    Kelly, Steven R.
    Wilson, Matthew W.
    Walton, R. Christopher
    PEDIATRIC BLOOD & CANCER, 2013, 60 (07) : E35 - E37
  • [6] CYCLOSPORINE OPHTHALMIC SOLUTION 0.09% IMPROVES THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE IN PATIENTS WHOSE DISEASE IS INADEQUATELY CONTROLLED ON CYCLOSPORINE OPHTHALMIC EMULSION 0.05%
    Johnston, J.
    Adler, R.
    Hessen, M.
    Nichols, K.
    Pflugfelder, S.
    Truett, K.
    Urbieta, M.
    Reynolds, R.
    VALUE IN HEALTH, 2024, 27 (06) : S32 - S32
  • [7] Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
    Burade, Vinod
    Zalawadia, Rishit
    Patel, Alpesh
    Ogundele, Abayomi
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 2747 - 2755
  • [8] An evaluation of Retaine (TM) ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
    Ousler, George, III
    Devries, Douglas K.
    Karpecki, Paul M.
    Ciolino, Joseph B.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 235 - 243
  • [9] Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
    Stonecipher, Karl G.
    Chia, Jenny
    Onyenwenyi, Ahunna
    Villanueva, Linda
    Hollander, David A.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 : 409 - 415
  • [10] Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
    White, Darrell E.
    Zhao, Yang
    Ogundele, Abayomi
    Fulcher, Nicole
    Acs, Annabel
    Moore-Schiltz, Laura
    Karpecki, Paul M.
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 2285 - 2292
1234